Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
EGG DROP SYDROME 76 VIRUS STRAIN BC 14; OIL ADJUVANT
INTERVET AUSTRALIA PTY LIMITED
vaccine - egg drop syndrome-
MISC. VACCINES OR ANTI SERA
EGG DROP SYDROME 76 VIRUS STRAIN BC 14 VACCINE-VIRAL Active 0.0 P; OIL ADJUVANT OIL Other 0.0 P
500mL
VM - Veterinary Medicine
INTERVET AUSTRALIA
POULTRY LAYERS (EGGS FOR HUMAN CONSUMP) | CAGED LAYERS | CHICKENS | CHOOKS | HEN
IMMUNOTHERAPY
AVIAN HAEMAGGLUTINATING ADENOVIRUS | ADENOVIRUS | EGG DROP SYNDROME
Poison schedule: 0; Withholding period: WHP: Zero (0) days; Host/pest details: POULTRY LAYERS (EGGS FOR HUMAN CONSUMP): [AVIAN HAEMAGGLUTINATING ADENOVIRUS]; Poison schedule: 0; Withholding period: WHP: NIL; Host/pest details: POULTRY LAYERS (EGGS FOR HUMAN CONSUMP): [AVIAN HAEMAGGLUTINATING ADENOVIRUS]; Poison schedule: 0; Withholding period: ; Host/pest details: POULTRY LAYERS (EGGS FOR HUMAN CONSUMP): [AVIAN HAEMAGGLUTINATING ADENOVIRUS]; Inactivated vaccine for the protection of laying hens against Egg Drop Syndrome' 76.Local tissue reactions may occur
Registered
2023-07-01
NOBILIS EDS INACTIVATED VACCINE FOR LAYING HENS 50008/133831 Product Name: APVMA Approval No: Label Name: NOBILIS EDS INACTIVATED VACCINE FOR LAYING HENS Signal Headings: FOR ANIMAL TREATMENT ONLY Constituent Statements: Inactivated EDS ’76 virus strain BC14 inducing ≥ 6.5 log2 HI units per dose in an adjuvant emulsion. Inactivated vaccine for the protection of laying hens against Egg Drop Syndrome ’76. Nobilis EDS contains one immunogenic strain of EDS ‘76 virus. The virus is inactivated with formalin. Subsequently it has been suspended in the aqueous phase of an oil adjuvant emulsion. Claims: Inactivated vaccine for the protection of laying hens against Egg Drop Syndrome ‘76. Net Contents: 500mL Directions for Use: Restraints: Do not mix with other vaccines. Contraindications: Precautions: Vaccinate healthy birds only. Side Effects: Vaccination reactions: In healthy birds no clinical reaction to vaccination will be observed. For some weeks after vaccination a slight swelling may be felt at the site of vaccination. Local tissue reactions may occur. Dosage and Administration: Shake the bottle well before use. Broached vials should be used within 3 hours. RLP APPROVED Allow to reach ambient temperature (15°C-25°C) before use. For IM or SC injection in hens 0.5 mL/dose. Before using vaccine allow it to reach ambient temperature (15°C-25°C). Each bird should be given 0.5 mL of vaccine intramuscularly in the thigh or chest muscle or subcutaneously into the lower part of the neck. Use the entire contents when first opened. Use sterile injection equipment. Recommended vaccination program Nobilis EDS should be given to birds approximately 16-20 weeks of age but not less than 4 weeks before the expected onset of lay. General Directions: Immunity: If vaccination has been carried out correctly the birds will develop antibodies at a level which provides protection against Egg Drop Syndrome ‘76. Withholding Periods: Zero (0) days. Trade Advice: Safety Directions: First Aid Instructions: If poisoning occurs, c Read the complete document
PRODUCT NAME: NOBILIS® EDS INACTIVATED VACCINE FOR LAYING HENS MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: JULY, 2014 PAGE: 1 OF 6 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited (trading as MSD Animal Health) Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Inactivated virus in an oil/water emulsion. TRADE NAME: NOBILIS ® EDS INACTIVATED VACCINE FOR LAYING HENS PRODUCT CODE: RECOMMENDED USE: Disease prevention by vaccination in laying and breeding poultry. APVMA NO: 50008 THIS VERSION ISSUED: Is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S25. Avoid contact with eyes. SUSDP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: White emulsion. Presented in 500mL bottle. ODOUR: No odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. The formaldehyde in this product is present at very low concentrations. However, persons with known sensitisation to formaldehyde should avoid contact with this product. INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. POTENTIAL HEALTH EFFECTS EMERGENCY OVERVIEW SECTION 2 - HAZARDS IDENTIFICATION SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY ISSUED BY: INTERVET AUSTRALIA PTY LIMITED (TRADING AS MSD ANIMAL HEALTH) 91-105 HARPIN STREET TEL: 1 800 033 461 (BUSINESS HOURS) BENDIGO EAST, VIC 3550, AUSTRALIA FAX: 1 800 81 Read the complete document